Search clinical trials for: benign prostate hyperplasia

Total 8990 results

Samsung Medical Center

Completed

Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

Korea, Republic of
Samsung Medical Center

Completed

Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)

Overactive Bladder | Benign Prostatic Hyperplasia

Korea, Republic of
Selcuk University

Suspended

Comparison of Different Energy Sources During TUR-P

Benign Prostatic Hypertrophy

Turkey
Saint-Joseph University

Completed

A Pumpkin Seed, Isoflavonoid and Cranberry Mix in LUTS/BPH

Benign Prostatic Hyperplasia

Lebanon
National Cheng-Kung University Hospital
National Cheng Kung University; National Research Program for Biopharmaceuticals... and other collaborators

Unknown

Taiwan ACE Beads for Embolization Therapy in Symptomatic Benign Prostatic Hyperplasia

Lower Urinary Tract Symptom | Benign Prostatic Hyperplasia (BPH)

Taiwan
Mansoura University

Completed

HoLEP vs. Greenlight 532nm-laser PVEP vs. Bipolar TURP in Management of Moderate/ Large BPH

Lower Urinary Tract Symptoms | Benign Prostate Hyperplasia

Egypt
Bangabandhu Sheikh Mujib Medical University, Dhaka...

Completed

Efficacy of Silodosin in the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

Bangladesh
Tampa General Hospital

Unknown

Benign Prostatic Hyperplasia and Prostate Size Greater Than 90 Grams

Benign Prostatic Hyperplasia

United States
Jeil Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Korea, Republic of
Group of Research in Minimally Invasive Techniques
Universidad de Zaragoza; Hospital Clínico Universitario Lozano Blesa

Withdrawn

Prospective Controlled Randomized Study of PAE vs TURP for BPH Treatment.

Benign Prostatic Hyperplasia

Spain
Laboratoires Bouchara-Recordati
ClinSearch

Completed

Interest of a Systematic Assessment of the Treatment of LUTS in the Management of BPH (UROEVAL)

Benign Prostatic Hyperplasia

France
Jena University Hospital
Boston Scientific Corporation

Completed

Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic Hyperplasia (EmboProstate)

Benign Prostatic Hyperplasia

Germany
Mansoura University

Completed

GreenLight Laser Photoselective Vaporization of the Prostate vs Bipolar Transurethral Vaporization of the Prostate; RCT

Benign Prostatic Hyperplasia

Egypt
University Hospital, Limoges

Terminated

Exploration of Ejaculation Changing Mechanism After Surgery for Benign Prostatic Hyperplasia (EMMECH)

Benign Prostatic Hyperplasia | Ejaculation | Prostate

France
Umeå University

Unknown

TURP; Complications and Outpatient Care

Benign Prostatic Hyperplasia

Sweden
Marmara University

Unknown

Benign Prostatic Hyperplasia and Glycosaminoglycan

Prostatic Hyperplasia

Turkey
Allergan

Completed

Safety and Efficacy of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

France, Poland, Korea, Republic of, Canada, United States, Germany, Philippines, Czechia
Intermountain Health Care, Inc.
NuView Diagnostics

Unknown

Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones. (VPAC)

Prostate Cancer | Kidney Stones | Benign Prostatic Hypertrophy | Bladder Stones

United States
University of Virginia
Siemens Medical Solutions

Unknown

Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia

Prostatic Hyperplasia | Hyperplasia | Male Urogenital Diseases | Prostatic Hypertrophy | Benign Prostatic Hyperplasia (BPH) | Genital Diseases, Male | Lower Urinary Tract Symptoms (LUTS) | Prostatism

United States
Medical University of Lodz

Completed

Serum Copeptin as a Predictor of the Risk of Hyponatremia After Transurethral Prostatectomy

Benign Prostatic Hyperplasia

Poland
Astellas Pharma Inc
Astellas Pharma Singapore Pte. Ltd.

Completed

A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)

Overactive Bladder

Japan, Korea, Republic of
JUNGNAM KWON

Completed

Moxibustion as an Adjuvant for Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms: a Pilot Study

Benign Prostatic Hyperplasia | Lower Urinary Tract Symptom | BPH | Benign Prostatic Hypertrophy

Korea, Republic of
Eli Lilly and Company

Terminated

A Study in Men With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States, Germany, France, Australia, Greece, Canada, Russian Federation, Italy
GlaxoSmithKline

Completed

Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia

Prostatic Hyperplasia

Korea, Republic of, China, Japan, Taiwan
NeoTract, Inc.

Completed

UroLift System TOlerability and ReCovery When Administering Local Anesthesia (LOCAL)

Benign Prostatic Hyperplasia

United States
Indiana Kidney Stone Institute
Richard Wolf Medical Instruments Corporation (RWMIC)

Completed

Randomized Controlled Trial Comparing Two Different Morcellators for HoLEP Procedures

Benign Prostatic Hypertrophy Requiring Surgical Intervention

United States
I.M. Sechenov First Moscow State Medical University

Completed

Benign Prostatic Hyperplasia and Ischemic Heart DIsease

Benign Prostatic Hyperplasia (BPH) | Lower Urinary Tract Symptoms (LUTS) | Ischaemic Heart Disease (IHD)
NeoTract, Inc.

Completed

Study of Median Lobe Prostatic UroLift Procedure

Benign Prostatic Hyperplasia (BPH)
PROCEPT BioRobotics

Completed

French Aquablation Clinical Investigation Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue

Benign Prostatic Hyperplasia (BPH)

France
University of Bari
Gaetano de Rienzo; Pasquale Ditonno; Francesco Di Modugno; Michele Battaglia; Giuseppe... and other collaborators

Unknown

Urodynamic Evaluation of Disobstrucitve Power of Aquablation VS Laser Techniques

Benign Prostatic Hyperplasia (BPH)

Italy
Zenflow, Inc.

Unknown

The Zenflow Spring System Feasibility and Safety Study (ZEST)

Benign Prostatic Hyperplasia

Bulgaria, New Zealand
Taha Uçar

Unknown

The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy

Pain | Lower Urinary Tract Symptoms | Bladder Cancer | Benign Prostate Hyperplasia | Hematuria

Turkey
University of Arkansas

Withdrawn

2017-03: A Single-Arm, Open-label Study of Anti-Signaling Lymphocytic Activation Molecule F7 (Anti-SLAMF7) Monoclonal Antibody (mAb) Therapy After Autologous Stem Cell Transplant in Patients With Multiple Myeloma

Multiple Myeloma

United States
Medi-Tate Ltd.

Completed

Assessing Safety & Efficacy of MediTate Temporary Implant in Subjects With Benign Prostate Hyperplasia

Benign Prostate Hyperplasia | Bladder Neck Obstruction

Israel
Rigshospitalet, Denmark

Completed

Prostatic Artery Embolization for Benign Prostatic Obstruction

Lower Urinary Tract Symptoms | Urological Manifestations | Prostatic Diseases | Hyperplasia Prostatic

Denmark
Materia Medica Holding

Completed

Clinical Trial of Safety and Efficacy of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and Risk of Progression

Benign Prostatic Hyperplasia

Russian Federation, Ukraine
Sophiris Bio Corp

Completed

Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia (TRIUMPH-1)

Benign Prostatic Hyperplasia

Canada
South Florida Medical Imaging, PA

Terminated

Prostate Artery Embolization as a Treatment for Benign Prostatic Hyperplasia in Men With Prostates Larger Than 90 Grams

Prostatic Hyperplasia

United States
Siami, Paul F., M.D.
GlaxoSmithKline

Completed

Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Vantia Ltd

Completed

Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC)

Nocturia

United States
VA Office of Research and Development
Merck Sharp & Dohme LLC; Endo Pharmaceuticals

Completed

5-Alpha Reductase and Anabolic Effects of Testosterone

Sarcopenia | Muscle Atrophy | Male Hypogonadism | Benign Prostate Hypertrophy

United States
National Institute of Diabetes and Digestive and...
George Washington University

Completed

Medical Therapy of Prostatic Symptoms (MTOPS)

Prostatic Hyperplasia | Prostatic Hypertrophy, Benign

United States
GlaxoSmithKline

Completed

Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects

Prostatic Hyperplasia

Japan
Johns Hopkins University

Completed

Ultrasound-Guided Photoselective Vaporization of the Prostate

Benign Prostatic Hyperplasia

United States
NeoTract, Inc.

Completed

The Safety and Effectiveness of UroLift: LIFT Pivotal Study (LIFT)

Benign Prostatic Hyperplasia

United States, Australia, Canada
Merck Sharp & Dohme LLC

Terminated

Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2)

Benign Prostatic Hyperplasia
GlaxoSmithKline

Terminated

Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia (FDC114785)

Prostatic Hyperplasia

Vietnam
GlaxoSmithKline

Completed

Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement (CONDUCT)

Prostatic Hyperplasia

Italy, Spain, United Kingdom, Netherlands, Greece, Romania, France, Germany
IMBiotechnologies Ltd.

Completed

Safety and Efficacy of OCL 503 in Prostate Artery Embolization

Benign Prostatic Hyperplasia | Benign Prostatic Hypertrophy

Canada
Light Sciences Oncology
Mundipharma Research Limited

Completed

A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States

Search clinical trials for: benign prostate hyperplasia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations